Loading
GT
GeneTether Therapeutics Inc. Stock: price and insider trades · Canada
GeneTether Therapeutics Inc.: what insiders have been doing
GeneTether Therapeutics Inc. is a listed company. Filings by its managers are published through SEDI. GeneTether Therapeutics Inc. has had no insider filing for more than a year; the last one goes back to 20 October 2023.
Looking back to 2022, when coverage begins, insiders filed 13 purchases and no sales.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
25
Thresholds
n/a
Buy Volume
€9,951
13 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 20 October 2023
Declarations25 total
10,421,974 sharesCommon SharesTSXSEDI:4199223
5,000 shares@ CA$0.181.3% of flowCommon SharesTSXSEDI:4022205
Canonical exit: 25 Jan 2023 (T+90)
1,500 shares@ CA$0.220.5% of flowCommon SharesTSXSEDI:4020607
5,000 shares@ CA$0.201.5% of flowCommon SharesTSXSEDI:4019974
Canonical exit: 17 Jan 2023 (T+90)
5,400 shares@ CA$0.254.0% of flowCommon SharesTSXSEDI:4018806
Canonical exit: 12 Jan 2023 (T+90)
5,000 shares@ CA$0.250.0% of flowCommon SharesTSXSEDI:4019008
Canonical exit: 12 Jan 2023 (T+90)
2,500 shares@ CA$0.2843.8% of flowCommon SharesTSXSEDI:4017709
Canonical exit: 9 Jan 2023 (T+90)
1,500 shares@ CA$0.2523.5% of flowCommon SharesTSXSEDI:4017707
Canonical exit: 9 Jan 2023 (T+90)
1,000 shares@ CA$0.2515.6% of flowCommon SharesTSXSEDI:4017708
Canonical exit: 9 Jan 2023 (T+90)
1,000 shares@ CA$0.27Common SharesTSXSEDI:4005645
Canonical exit: 21 Dec 2022 (T+90)
12,000 shares@ CA$0.230.1% of flowCommon SharesTSXSEDI:3999607
Canonical exit: 7 Dec 2022 (T+90)
12,400 shares@ CA$0.26Common SharesTSXSEDI:3994745
Canonical exit: 27 Nov 2022 (T+90)
2,500 shares@ CA$0.12Common SharesTSXSEDI:3994576
Canonical exit: 24 Nov 2022 (T+90)
1,500 shares@ CA$0.25Common SharesTSXSEDI:3994578
Canonical exit: 24 Nov 2022 (T+90)
2,500 shares@ CA$0.16Common SharesTSXSEDI:3994577
Canonical exit: 24 Nov 2022 (T+90)
Common SharesTSXSEDI:3916376
5,718,824 shares@ CA$0.60100.0% of flowCommon SharesTSXSEDI:3916449
55,000 shares@ CA$0.60100.0% of flowCommon SharesTSXSEDI:3916445
110,000 shares@ CA$0.60100.0% of flowCommon SharesTSXSEDI:3916440
Common SharesTSXSEDI:3912095
Common SharesTSXSEDI:3912114
Common SharesTSXSEDI:3912111
Common SharesTSXSEDI:3912104
Common SharesTSXSEDI:3912091
Common SharesTSXSEDI:3912083
25 of 25 declarations
About GeneTether Therapeutics Inc.
GeneTether Therapeutics Inc. is a biotechnology company focused on developing innovative gene therapies. It is listed on the Toronto Stock Exchange under the symbol XTSE.
